Quantification of Abdominal Muscle Mass and Diagnosis of Sarcopenia with Cross-Sectional Imaging in Patients with Polycystic Kidney Disease: Correlation with Total Kidney Volume

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Mar 25

PMID 35328308

Authors

Chih-Horng Wu

Tai-Shuan Lai

Yung-Ming Chen

Chyi-Mong Chen

Shun-Chung Yang

Po-Chin Liang

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic kidney disease (PKD) is an inherited disorder characterized by renal cysts that may mask lean body loss. This study quantified and compared muscle mass by using computed tomography (CT) and magnetic resonance imaging (MRI) images between the PKD and control groups and correlated muscle mass with total kidney volume (TKV). Methods: We retrospectively enrolled patients who had a new diagnosis of PKD from May 2015 to May 2016. The CT and MRI images at the third lumbar level were processed to measure the total abdominal muscle (TAM) area for the diagnosis of sarcopenia, and TKV was estimated using the ellipsoid formula. Results: We included 37 women and 25 men (mean age: 50.40 years) in the PKD group. There was no difference in body mass index and albumin levels, but significant differences in creatinine level (p < 0.001), TAM area (p = 0.047), and TKV (p < 0.001), were noted between the two groups. A significantly negative correlation was observed between TKV and TAM area after adjustment for body height (r = −0.217, p = 0.003). Conclusions: CT and MRI images can accurately diagnose sarcopenia, which may be masked by cysts in patients with PKD.

Citing Articles

Advances in sarcopenia and urologic disorders.

Zhao T, Mao W, Hu M, Yu Q, Peng X, Ji J Front Nutr. 2024; 11:1475977.

PMID: 39568720 PMC: 11578050. DOI: 10.3389/fnut.2024.1475977.

A Primer for Utilizing Deep Learning and Abdominal MRI Imaging Features to Monitor Autosomal Dominant Polycystic Kidney Disease Progression.

Zhu C, He X, Blumenfeld J, Hu Z, Dev H, Sattar U Biomedicines. 2024; 12(5).

PMID: 38791095 PMC: 11118119. DOI: 10.3390/biomedicines12051133.

References

Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S . Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015; 34(3):335-40. DOI: 10.1016/j.clnu.2015.03.001. View

Suwabe T, Ubara Y, Sekine A, Ueno T, Yamanouchi M, Hayami N . Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2017; 32(7):1176-1183. DOI: 10.1093/ndt/gfx186. View

Woodrow G, Oldroyd B, Turney J, Smith M . Influence of changes in peritoneal fluid on body-composition measurements by dual-energy X-ray absorptiometry in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr. 1996; 64(2):237-41. DOI: 10.1093/ajcn/64.2.237. View

Kim J, Kim S, Oh J, Lee Y, Noh J, Kim H . Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2017; 34(3):599-607. PMC: 6506738. DOI: 10.3904/kjim.2017.083. View

Gomez-Perez S, Haus J, Sheean P, Patel B, Mar W, Chaudhry V . Measuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: A Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enteral Nutr. 2015; 40(3):308-18. PMC: 4767633. DOI: 10.1177/0148607115604149. View

Grantham J, Torres V, Chapman A, Guay-Woodford L, Bae K, King Jr B . Volume progression in polycystic kidney disease. N Engl J Med. 2006; 354(20):2122-30. DOI: 10.1056/NEJMoa054341. View

Greiber S, Mitch W . Mechanisms for protein catabolism in uremia: metabolic acidosis and activation of proteolytic pathways. Miner Electrolyte Metab. 1992; 18(2-5):233-6. View

Paris M, Tandon P, Heyland D, Furberg H, Premji T, Low G . Automated body composition analysis of clinically acquired computed tomography scans using neural networks. Clin Nutr. 2020; 39(10):3049-3055. PMC: 7374050. DOI: 10.1016/j.clnu.2020.01.008. View

Isoyama N, Qureshi A, Avesani C, Lindholm B, Barany P, Heimburger O . Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014; 9(10):1720-8. PMC: 4186520. DOI: 10.2215/CJN.10261013. View

10.

Patel S, Molnar M, Tayek J, Ix J, Noori N, Benner D . Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2012; 4(1):19-29. PMC: 3581614. DOI: 10.1007/s13539-012-0079-1. View

11.

Prado C, Lieffers J, McCargar L, Reiman T, Sawyer M, Martin L . Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008; 9(7):629-35. DOI: 10.1016/S1470-2045(08)70153-0. View

12.

Yu S, Visvanathan T, Field J, Ward L, Chapman I, Adams R . Lean body mass: the development and validation of prediction equations in healthy adults. BMC Pharmacol Toxicol. 2014; 14:53. PMC: 3833312. DOI: 10.1186/2050-6511-14-53. View

13.

Higashihara E, Nutahara K, Okegawa T, Tanbo M, Hara H, Miyazaki I . Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease. Nephron. 2015; 129(4):253-62. DOI: 10.1159/000381476. View

14.

Bhatla B, Moore H, Emerson P, Keshaviah P, Prowant B, Nolph K . Lean body mass estimation by creatinine kinetics, bioimpedance, and dual energy x-ray absorptiometry in patients on continuous ambulatory peritoneal dialysis. ASAIO J. 1995; 41(3):M442-6. DOI: 10.1097/00002480-199507000-00048. View

15.

Guiu B, Petit J, Loffroy R, Ben Salem D, Aho S, Masson D . Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology. 2008; 250(1):95-102. DOI: 10.1148/radiol.2493080217. View

16.

Pei Y, Obaji J, Dupuis A, Paterson A, Magistroni R, Dicks E . Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2008; 20(1):205-12. PMC: 2615723. DOI: 10.1681/ASN.2008050507. View

17.

Cesari M, Fielding R, Pahor M, Goodpaster B, Hellerstein M, van Kan G . Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle. 2012; 3(3):181-90. PMC: 3424187. DOI: 10.1007/s13539-012-0078-2. View

18.

Mourtzakis M, Prado C, Lieffers J, Reiman T, McCargar L, Baracos V . A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008; 33(5):997-1006. DOI: 10.1139/H08-075. View

19.

Whittle M, Simoes R . Hereditary polycystic kidney disease: genetic diagnosis and counseling. Rev Assoc Med Bras (1992). 2014; 60(2):98-102. DOI: 10.1590/1806-9282.60.01.004. View

20.

Guanabens N, Monegal A, Muxi A, Martinez-Ferrer A, Reyes R, Caballeria J . Patients with cirrhosis and ascites have false values of bone density: implications for the diagnosis of osteoporosis. Osteoporos Int. 2011; 23(4):1481-7. DOI: 10.1007/s00198-011-1756-1. View